LyP-2

LyP-2, an exquisitely engineered peptide specifically tailored for the dynamic landscape of the biomedical sphere, emanates as a beacon of hope to tackle an array of cancers, spanning from the intricate web of breast carcinoma to the inimical tendrils of lung malignancies. Compendious investigations have meticulously unfolded the fascinating saga of LyP-2's phenomenal anti-neoplastic prowess, meticulously orchestrating a symphony of targeted receptor engagement, discreetly halting cancer cell proliferation, and unyieldingly inducing the majestic art of apoptotic cell demise.

Online Inquiry